Antiepileptic drugs and apoptosis in the developing brain

Annals of the New York Academy of Sciences

Volumn 993, Issue , 2003, Pages 103-114

  Bittigau, Petra ^a   Sifringer, Marco ^a   Ikonomidou, Chrysanthy ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Apoptosis; Development; Neurodegeneration; Neurotrophin; Rat

Indexed keywords

ANTICONVULSIVE AGENT; CLONAZEPAM; DIAZEPAM; ESTRADIOL; NEUROTROPHIN; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT THERAPY; APOPTOSIS; BRAIN DEVELOPMENT; CONCENTRATION RESPONSE; CONFERENCE PAPER; HISTOPATHOLOGY; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALIA;

EID: 0038389588     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07517.x     Document Type: Conference Paper

References (34)

1. HAUSER, W.A. 1994. The prevalence and incidence of convulsive disorders in children. Epilepsia 35(Suppl. 2): S1-S6.
2. TAYLOR, C.P. & B.S. MELDRUM. 1995. Na+ channels as targets for neuroprotective drugs. Trends Pharmacol. Sci. 16: 309-316.
3. MELDRUM, B.S. 1996. Update on the mechanism of action of antiepileptic drugs. Epilepsia 37(Suppl. 6): S4-S11.
4. BRODIE, M.J. & M.A. DICHTER. 1996. New antiepileptic drugs. N. Engl. J. Med. 334: 168-175.
5. GIDAL, B.E., M.D. PRIVITERA, R.D. SHETH & J.T. GILMAN. 1999. Vigabatrin: a novel therapy for seizure disorders. Ann. Pharmacother. 33: 1277-1286.
6. SPEIDEL, B.D. & S.R. MEADOW. 1972. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 308: 839-843.
7. STRICKLER, S.M., L.V. DANSKY, et al. 1985. Genetic predisposition to phenytoin-induced birth defects. Lancet 2: 746-749.
8. JONES, K.L., R.V. LACRO, et al. 1989. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N. Engl. J. Med. 320: 1661-1666.
9. BUEHLER, B.A., D. DELIMONT, et al. 1990. Prenatal prediction of risk of the fetal hydantoin syndrome. N. Engl. J. Med. 322: 1567-1572.
10. HOLMES, L.B., E.A. HARVEY, et al. 2001. The teratogenicity of anticonvulsant drugs. N. Engl. J. Med. 344: 1132-1138.
11. ZAHN, C.A. 1998. Neurologic care of pregnant women with epilepsy. Epilepsia 39(Suppl. 8): S26-S31.
12. FARWELL, J.R., Y.J. LEE, et al. 1990. Phenobarbital for febrile seizures - effects on intelligence and on seizure recurrence. N. Engl. J. Med. 322: 364-369.
13. REINISCH, J.M., S.A. SANDERS, et al. 1995. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274: 1518-1525.
14. SULZBACHER, S., J.R. FARWELL, et al. 1999. Late cognitive effects of early treatment with phenobarbital. Clin. Pediatr. Philad. 38: 387-394.
15. THORP, J.A., M. O'CONNOR, et al. 1999. Does perinatal phenobarbital exposure affect developmental outcome at age 2? Am. J. Perinatol. 16: 51-60.
16. DESSENS, A.B., P.T. COHEN-KETTENIS, et al. 2000. Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems. Acta Paediatr. 89: 533-541.
17. IKONOMIDOU, C., F. BOSCH, et al. 1999. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-74.
18. IKONOMIDOU, C., P. BITTIGAU, et al. 2000. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287: 1056-1060.
19. DEOLMOS, J.S. & W.R. INGRAM. 1971. An improved cupric-silver method for impregnation of axonal and terminal degeneration. Brain Res. 33: 523-529.
20. GUNDERSEN, H.J.G., T.F. BENDTSEN, et al. 1988. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379-394.
21. ISHIMARU, M.J., C. IKONOMIDOU, et al. 1999. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J. Comp. Neurol. 408: 461-476.
22. HUANG, E.J. & L. REICHARDT. 2001. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24: 677-736.
23. BEHL, C. & D. MANTHEY. 2000. Neuroprotective activities of estrogen: an update. J. Neurocytol. 29: 351-359.
24. WLAZ, P., Z. ROLINSKI, et al. 1992. Anticonvulsant activity of carbamazepine and diphenylhydantoin against maximal electroshock in mice chronically treated with aminophylline. J. Neural Trans. Gen. Sect. 89: 41-48.
25. RATAUD, J., F. DEBARNOT, et al. 1994. Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents. Neurosci. Lett. 172: 19-23.
26. TURSKI, W.A., E.A. CAVALHEIRO, et al. 1987. Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain Res. 434: 281-305.
27. RENFRAY, G., H. SCHLINGER, et al. 1989. Effects of phenytoin and phenobarbital on schedule-controlled responding and seizure activity in the amygdala-kindled rat. J. Pharmacol. Exp. Ther. 248: 967-973.
28. WALTON, N.Y. & D.M. TREIMAN. 1989. Phenobarbital treatment of status epilepticus in a rodent model. Epilepsy Res. 4: 216-221.
29. WALKER, M.C. 1998. The epidemiology and management of status epilepticus. Curr. Opin. Neurol. 11: 149-154.
30. WALTON, N.Y. & D.M. TREIMAN. 1992. Valproic acid treatment of experimental status epilepticus. Epilepsy Res. 12: 199-205.
31. DALBY, N.O. & E.B. NIELSEN. 1997. Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res. 28: 63-72.
32. VENTERS, H.D., R. DANTZER & K.W. KELLEY. 2000. A new concept in neurodegeneration: TNFα is a silencer of survival signals. Trends Neurosci. 23: 175-180.
33. DOBBING, J. & J. SANDS. 1979. Comparative aspects of the brain growth spurt. Early Hum. Dev. 3: 79-83.
34. TROTTER, A. & F. POHLANDT. 2000. The replacement of oestradiol and progesterone in very premature infants. Ann. Med. 32: 608-614.